Skip to main content

TD Asset Management Inc

Source: SEC Form 13F · as of Mar 2026

TD Asset Management Inc holds 77 biotech & pharma companies tracked by BioSniper, totaling $1.33B in value as of Mar 2026 (SEC Form 13F).

Companies held

77

Total value held

$1.33B

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.3,372,079$470.0M
REGNREGENERON PHARMACEUTICALS, INC.350,923$271.1M
ALNYALNYLAM PHARMACEUTICALS, INC.281,848$93.3M
ARGXARGENX SE80,824$59.0M
IONSIONIS PHARMACEUTICALS INC529,954$39.8M
RVMDREVOLUTION MEDICINES, INC.317,811$30.9M
CYTKCYTOKINETICS INC420,846$27.7M
INSMINSMED Inc163,424$26.7M
ROIVRoivant Sciences Ltd.715,282$19.8M
PTGXProtagonist Therapeutics, Inc183,700$19.4M
PCVXVaxcyte, Inc.312,762$18.2M
SMMTSummit Therapeutics Inc.956,894$18.1M
APGEApogee Therapeutics, Inc.184,792$15.6M
NUVLNuvalent, Inc.137,764$14.1M
INCYIncyte Corp.142,983$13.5M
SRRKScholar Rock Holding Corp223,064$11.0M
BBIOBridgeBio Pharma, Inc.136,502$10.1M
GPCRStructure Therapeutics Inc.204,762$9.9M
DNTHDianthus Therapeutics, Inc. /DE/116,576$9.8M
CNTACentessa Pharmaceuticals plc242,044$9.6M
MRNAModerna, Inc.179,583$9.1M
TEVATeva Pharmaceutical Industries Limited253,661$7.6M
ABVXAbivax SA65,548$7.3M
SYRESpyre Therapeutics, Inc.137,390$6.9M
TENXTENAX THERAPEUTICS, INC.399,184$6.4M
KODKodiak Sciences Inc.162,298$6.2M
BCAXBicara Therapeutics Inc.269,718$5.4M
DNLIDenali Therapeutics Inc.255,766$4.9M
TERNTerns Pharmaceuticals, Inc.89,594$4.7M
IMTXImmatics N.V.470,444$4.6M
AXSMAxsome Therapeutics, Inc.27,132$4.6M
ALMSALUMIS INC.191,202$4.2M
BEAMBeam Therapeutics Inc.176,024$4.2M
IMCRImmunocore Holdings plc135,828$4.1M
ORKAOruka Therapeutics, Inc.75,696$3.7M
RYTMRHYTHM PHARMACEUTICALS, INC.38,778$3.4M
SIONSionna Therapeutics, Inc.82,996$3.3M
ORICOric Pharmaceuticals, Inc.258,602$3.3M
IMVTImmunovant, Inc.131,352$3.3M
ONCBeOne Medicines Ltd.10,014$3.0M
NRIXNurix Therapeutics, Inc.189,250$2.9M
PVLAPALVELLA THERAPEUTICS, INC.22,746$2.8M
ARWRARROWHEAD PHARMACEUTICALS, INC.44,720$2.8M
MLTXMoonLake Immunotherapeutics142,706$2.7M
STOKStoke Therapeutics, Inc.74,400$2.4M
CLDXCelldex Therapeutics, Inc.70,292$2.2M
TNGXTango Therapeutics, Inc.102,600$2.1M
RLAYRelay Therapeutics, Inc.214,170$2.1M
COGTCogent Biosciences, Inc.52,590$2.0M
OCULOCULAR THERAPEUTIX, INC238,000$2.0M
IRONDisc Medicine, Inc.30,476$1.9M
CLYMClimb Bio, Inc.250,102$1.7M
CGEMCullinan Therapeutics, Inc.114,400$1.6M
OLMAOlema Pharmaceuticals, Inc.106,214$1.6M
LQDALiquidia Corp41,944$1.6M
PHVSPharvaris N.V.54,826$1.5M
BHVNBiohaven Ltd.177,390$1.5M
RNAAtrium Therapeutics Inc.111,200$1.5M
IOVAIOVANCE BIOTHERAPEUTICS, INC.340,252$1.2M
VRDNViridian Therapeutics, Inc.\DE55,386$1.1M
MPLTMapLight Therapeutics, Inc.47,768$971K
AGIOAGIOS PHARMACEUTICALS, INC.23,732$803K
AVTXAvalo Therapeutics, Inc.51,408$768K
TRDAEntrada Therapeutics, Inc.53,588$676K
TECXTectonic Therapeutic, Inc.20,400$631K
TVTXTravere Therapeutics, Inc.17,534$521K
BBOTBridgeBio Oncology Therapeutics, Inc.57,572$515K
IMMXImmix Biopharma, Inc.53,200$485K
BCYCBICYCLE THERAPEUTICS PLC91,992$427K
ADPTAdaptive Biotechnologies Corp30,670$426K
BDTXBlack Diamond Therapeutics, Inc.195,930$417K
ELVNEnliven Therapeutics, Inc.8,600$337K
RCKTRocket Pharmaceuticals Inc.68,046$244K
LENZLENZ Therapeutics, Inc.24,610$225K
NUVBNuvation Bio Inc.30,462$131K
ANNXAnnexon, Inc.22,760$126K
DNAGinkgo Bioworks Holdings Inc.13,046$80K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.